A High-throughput Shigella-specific Bactericidal Assay

被引:6
作者
Weerts, Hailey P. [1 ]
Yu, Jigui [2 ]
Kaminski, Robert W. [1 ]
Nahm, Moon H. [2 ]
机构
[1] Walter Reed Army Inst Res, Bacterial Dis Branch, Dept Enter Infect, Silver Spring, MD USA
[2] Univ Alabama Birmingham, Birmingham, AL 35294 USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2019年 / 144期
关键词
Immunology and Infection; Issue; 144; Shigella; antibody; functional assay; immunoassay; complement; bactericidal; high-throughput; VACCINE; DIARRHEA; LONG;
D O I
10.3791/59164
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Serum bactericidal assays (SBAs) measure the functional activity of antibodies and have been used for many decades. SBAs directly measure antibody killing activity by assessing the ability of antibodies in serum to bind to bacteria and activate complement. This complement activation results in the lysis and killing of the target bacteria. These assays are valuable because they go beyond quantifying antibody production to elucidate the biological functions that these antibodies have, allowing researchers to study the role that antibodies may play in preventing infection. SBAs have been used to study immune responses for many human pathogens, but there is no widely accepted methodology for Shigella at present. Historically, SBAs have been very labor-intensive, requiring many time-consuming steps to accurately quantify surviving bacteria. This protocol describes a simple, robust, and high-throughput assay that measures functional antibodies specific for Shigella in serum in vitro. The method described here offers many advantages over traditional SBAs, including the use of frozen bacterial stocks, 96 well assay plates, a micro-culture system, and automated colony-counting. All of these modifications make this assay less labor-intensive and more high-throughput. This protocol is simpler and faster to perform than traditional SBAs while still using simple technologies and readily available reagents. The protocol has been successfully applied in multiple independent laboratories and the assay is robust and reproducible. The assay can be used to assess immune responses in pre-clinical as well as clinical studies. Quantifying shigellacidal antibody titers both before and after antigen exposure (either by immunization or infection) allows for a broader understanding of how functional antibody responses are generated and their contribution to protective immunity. The development of this standardized, well-characterized assay may greatly facilitate Shigella vaccine design.
引用
收藏
页数:9
相关论文
共 17 条
[1]  
Abu Sayem M, 2011, J HEALTH POPUL NUTR, V29, P429
[2]   Progress and pitfalls in Shigella vaccine research [J].
Barry, Eileen M. ;
Pasetti, Marcela F. ;
Sztein, Marcelo B. ;
Fasano, Alessio ;
Kotloff, Karen L. ;
Levine, Myron M. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (04) :245-255
[3]   Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies [J].
Burton, Robert L. ;
Nahm, Moon H. .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (09) :1004-1009
[4]   Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method [J].
Jang, Mi Seon ;
Sahastrabuddhe, Sushant ;
Yun, Cheol-Heui ;
Han, Seung Hyun ;
Yang, Jae Seung .
MICROBIAL PATHOGENESIS, 2016, 97 :19-26
[5]   Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model [J].
Kim, Hye-Youn ;
Kim, Jinhee ;
Huyen Trang Ha Thi ;
Bang, Ok-Sun ;
Lee, Won-Suk ;
Hong, Suntaek .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 16
[6]   Clinical trials of Shigella vaccines:: two steps forward and one step back on a long, hard road [J].
Levine, Myron M. ;
Kotloff, Karen L. ;
Barry, Eileen M. ;
Pasetti, Marcela F. ;
Sztein, Marcelo B. .
NATURE REVIEWS MICROBIOLOGY, 2007, 5 (07) :540-553
[7]   Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development [J].
Livio, Sofie ;
Strockbine, Nancy A. ;
Panchalingam, Sandra ;
Tennant, Sharon M. ;
Barry, Eileen M. ;
Marohn, Mark E. ;
Antonio, Martin ;
Hossain, Anowar ;
Mandomando, Inacio ;
Ochieng, John B. ;
Oundo, Joseph O. ;
Qureshi, Shahida ;
Ramamurthy, Thandavarayan ;
Tamboura, Boubou ;
Adegbola, Richard A. ;
Hossain, Mohammed Jahangir ;
Saha, Debasish ;
Sen, Sunil ;
Faruque, Abu Syed Golam ;
Alonso, Pedro L. ;
Breiman, Robert F. ;
Zaidi, Anita K. M. ;
Sur, Dipika ;
Sow, Samba O. ;
Berkeley, Lynette Y. ;
O'Reilly, Ciara E. ;
Mintz, Eric D. ;
Biswas, Kousick ;
Cohen, Dani ;
Farag, Tamer H. ;
Nasrin, Dilruba ;
Wu, Yukun ;
Blackwelder, William C. ;
Kotloff, Karen L. ;
Nataro, James P. ;
Levine, Myron M. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (07) :933-941
[8]   Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays [J].
Maslanka, SE ;
Gheesling, LL ;
Libutti, DE ;
Donaldson, KBJ ;
Harakeh, HS ;
Dykes, JK ;
Arhin, FF ;
Devi, SJN ;
Frasch, CE ;
Huang, JC ;
KrizKuzemenska, P ;
Lemmon, RD ;
Lorange, M ;
Peeters, CCAM ;
Quataert, S ;
Tai, JY ;
Carlone, GM ;
Mills, EL ;
Ashton, FE ;
Diepevaen, J ;
Bielecki, J ;
Bybel, M ;
Cloutier, M ;
Poolman, JT .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (02) :156-167
[9]  
Nahm MH, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00146-18, 10.1128/msphere.00146-18]
[10]   Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout [J].
Necchi, Francesca ;
Saul, Allan ;
Rondini, Simona .
PLOS ONE, 2017, 12 (02)